LLT change status of patients with definite or probable FH at 6-month of follow-up.

Discontinued defined as any LLT prescription at index date but no LLT prescription at 6-month of follow-up. Switching defined as different LLT/combination of LLT prescribed during follow-up than the LLT prescribed at index date. Increase defined as one or more new LLT started during follow-up with index drugs also still continued. Decrease defined as one or more LLT at index date no longer taken at follow-up, but one or more LLT at index date still continued. No change defined as no change in LLT drugs prescribed between index date and follow-up.

Verfasser: Jean Ferrières (147944)
Victoria Banks (11218345)
Demetris Pillas (252463)
Francesco Giorgianni (523751)
Laurene Gantzer (11218348)
Beranger Lekens (11218351)
Lea Ricci (11218354)
Margaux Dova-Boivin (11218357)
Jean-Vannak Chauny (11218360)
Guillermo Villa (3705187)
Gaelle Désaméricq (3119565)
Dokumenttyp: Image
Erscheinungsdatum: 2021
Schlagwörter: Biochemistry / Medicine / Biotechnology / Cancer / Science Policy / Infectious Diseases / Virology / Computational Biology / Environmental Sciences not elsewhere classified / Chemical Sciences not elsewhere classified / 6- month / PCSK / French sample / cohort study Background / statin / Health Improvement Network / LLT / THIN / LDL-C goal / Untreated Familial Hypercholesterolemia / management / Results 116 patients / DLCN / follow-up / Dutch Lipid Clinic Network / FH patients
Sprache: unknown
Permalink: https://search.fid-benelux.de/Record/base-29019124
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doi.org/10.1371/journal.pone.0255345.g003